Improving access to HbA1c measurement in sub Saharan Africa (LT07-135)

Last update: 19/04/2017
  • Location :
    Guinea and Cameroon
    Topic :
    Duration :
    November 1, 2008 - April 12, 2012
    Main Institution :
    Institute of Health and Society, Newcastle University (United Kingdom)
    Other institution :
    Health of Population in Transition (Cameroon) Ministry of Heath (Guinea)
    Principal investigator :
    Dr Eugene Sobngwi
    Other investigator :
    Dr N.Balde
    Amount allocated :
    USD 398,258
    Objectives :
    Glycated haemoglobin (HbA1c) is the best surrogate of average blood glucose control in people with diabetes. Large-scale studies in the USA and UK have demonstrated that lowering HbA1c significantly reduces diabetes complications. Moreover, immediate feedback of HbA1c measurement to patients improves control. However, HbA1c measurement is unavailable in most parts of Africa, a continent with one of the highest burden of diabetes. To translate these evidences, we will provide affordable access to HbA1c measurement and relevant education in 2 African countries, aiming at a significant improvement in diabetes control. We will develop a training and cost-recovery scheme with local health authorities for long-term sustainability.

Results to date (November 2012):

Overall, there was a 1% reduction in HbA1c in 12 months – 40% of the total sample reduced their HbA1c by more than 1 point. HbA1c determination has become routine in all 10 centres.


  • Congrès de la Société Francophone Africaine de Diabétologie, Dakar (Senegal), December 2010 (2 posters)
  • 6emes Journée Internationales d'Endocrinologie de Cotonou (Benin), January 2011
  • Congrès annuel de la Société Francophone du Diabète, Geneva (Switzerland), March 2011 (2 posters)
  • EASD 2012, Berlin (Germany), October 2012
  • 2nd African Diabetes Congress, Yaounde (Cameroun), February 2014


© 2022 International Diabetes Federation Disclaimer Privacy policy